CAS: 1083-57-4; N-(4-Ethoxyphenyl)-3-Hydroxybutanamide

该化合物是一种属于酚类化合物的化学化合物,主要被确认为是一种用于抗炎和止痛剂的化学化合物,Bucetin展示了能够抑制作为炎和疼痛媒介的prostalandins合成的可抑制其刺激和疼痛的异丙烯的特性,该化合物的特点是能够与各种生物途径互动,从而引起对药理学研究的兴趣.在物理特性方面,bustin通常是一种白色到非白晶状的粉末,在有机溶剂中可溶解,但在水中溶解性有限,其分子结构包括一种苯丙基氢氧基化合物组,有助于其再活性和生物活动.已经研究过它的潜在治疗用途,尽管其使用可能因安全和效能问题而受到限制.关于任何化学物质,在实验室或工业环境中与Bucentin合作时,应当注意到适当的处理和安全措施.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号122-82-7 对乙酰基乙酰氨基苯乙醚

合成工艺路线路线简述

    📜对乙氧基-N-乙酰乙酰苯胺置于甲醇,镍体系中,化学反应生成羟丁酰胺苯醚
    参考文献:Beta-Hydroxybutyric Acid Para-Phenetidide And A Process For Preparing It
    标题:Beta-Hydroxybutyric Acid Para-Phenetidide And A Process For Preparing It

    专利信息


    专利号:US-2024287041-A1
    优先权日:2021-05-20
    标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
    发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

    专利号:AU-2022276509-A1
    优先权日:2021-05-20
    标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:WO-2022246227-A1
    优先权日:2021-05-20
    标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:WO-2010121673-A1
    优先权日:2009-04-22
    标 题 :Synthesis of 3-{[(2r)-1-methylpyrrolidin-2-yl]methyl}-5-[2-(phenylsulfonyl)ethyl]-1h-indole

    专利号:US-10363247-B2
    优先权日:2015-08-18
    标 题:(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted benzofuranyl compounds and, more particularly, to a compound represented by Structural Formula 1a: (I) or a pharmaceutically acceptable salt thereof. The invention also includes the synthesis and use of the compound of Structural Formula 1a, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of diseases or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disease) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    1. Nohmi T, Ishidate M Jr, Hiratsuka A, Watabe T. Mechanism of metabolic activation of the analgetic bucetin to bacterial mutagens by hamster liver microsomes. Chem Pharm Bull (Tokyo). 1985 Jul;33(7):2877-85. doi: 10.1248/cpb.33.2877. 1 Suppl
    1:86-92.

    合成参考文献


    摘要:Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology., 62(123), 1966 []
    摘要:Arzneimittel-Forschung. Drug Research., 15(727), 1965 []
    摘要:S72 | NTUPHTW | Pharmaceutically Active Substances from National Taiwan University | DOI:10.5281/zenodo.3955664
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知